UA94914C2 - Способ получения солей тиотропия - Google Patents

Способ получения солей тиотропия

Info

Publication number
UA94914C2
UA94914C2 UAA200802325A UAA200802325A UA94914C2 UA 94914 C2 UA94914 C2 UA 94914C2 UA A200802325 A UAA200802325 A UA A200802325A UA A200802325 A UAA200802325 A UA A200802325A UA 94914 C2 UA94914 C2 UA 94914C2
Authority
UA
Ukraine
Prior art keywords
tiotropium salts
producing tiotropium
producing
salts
formula
Prior art date
Application number
UAA200802325A
Other languages
English (en)
Ukrainian (uk)
Inventor
Йорг Бранденбург
Вальдемар Пфренгле
Original Assignee
Бьорингер Ингельхайм Фарма Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Бьорингер Ингельхайм Фарма Гмбх & Ко. Кг filed Critical Бьорингер Ингельхайм Фарма Гмбх & Ко. Кг
Publication of UA94914C2 publication Critical patent/UA94914C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В заявке описан новый способ получения солей тиотропия общей формулы (1), (1)в которой X- может иметь указанные в формуле изобретения и в описании значения.
UAA200802325A 2005-07-27 2006-07-24 Способ получения солей тиотропия UA94914C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005035112A DE102005035112A1 (de) 2005-07-27 2005-07-27 Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen

Publications (1)

Publication Number Publication Date
UA94914C2 true UA94914C2 (ru) 2011-06-25

Family

ID=37110331

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200802325A UA94914C2 (ru) 2005-07-27 2006-07-24 Способ получения солей тиотропия

Country Status (24)

Country Link
US (5) US20070027320A1 (ru)
EP (2) EP3153512A1 (ru)
JP (1) JP5210861B2 (ru)
KR (1) KR101299929B1 (ru)
CN (2) CN101309920A (ru)
AR (1) AR057690A1 (ru)
AU (1) AU2006274012B2 (ru)
BR (1) BRPI0614062B8 (ru)
CA (1) CA2616222C (ru)
DE (1) DE102005035112A1 (ru)
DK (1) DK1910354T3 (ru)
EA (1) EA014271B1 (ru)
EC (1) ECSP088138A (ru)
ES (1) ES2613952T3 (ru)
HU (1) HUE032259T2 (ru)
IL (1) IL188989A (ru)
MX (1) MX2008001093A (ru)
NO (2) NO340877B1 (ru)
NZ (1) NZ566039A (ru)
PL (1) PL1910354T3 (ru)
TW (3) TWI486345B (ru)
UA (1) UA94914C2 (ru)
WO (1) WO2007012626A2 (ru)
ZA (1) ZA200711113B (ru)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008089852A1 (de) * 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
EP1950196A1 (de) * 2007-01-29 2008-07-30 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Ammoniumhexafluorophosphaten
EP1953156A1 (de) * 2007-01-29 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopiniumsalzen
EP1997819A1 (de) * 2007-05-25 2008-12-03 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von Scopinestern
EP2036898A2 (de) * 2007-09-13 2009-03-18 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung von 1,3-Dioxolan-2Onen sowie von Carbonsäureestern durch Transacylierung unter Basischen Reaktionsbedingungen
CN101918401A (zh) * 2008-01-10 2010-12-15 基因里克斯(英国)有限公司 用于制备东莨菪醇酯的新方法
WO2011015884A1 (en) * 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
CA2768553C (en) 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
CZ305012B6 (cs) * 2012-03-30 2015-03-25 Zentiva, K.S. Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu
WO2021133280A1 (en) * 2019-12-27 2021-07-01 Deva Holding An improved process for preparation of scopine hydrobromide

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US7441045B2 (en) * 1999-12-13 2008-10-21 F5 Networks, Inc. Method and system for balancing load distribution on a wide area network
US6934686B1 (en) 2000-06-30 2005-08-23 I2 Technologies Us, Inc. Warranty transaction system and method
US7574499B1 (en) * 2000-07-19 2009-08-11 Akamai Technologies, Inc. Global traffic management system using IP anycast routing and dynamic load-balancing
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) * 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
US7237017B1 (en) * 2001-03-13 2007-06-26 Panamsat Corporation Micronode in a satellite based content delivery system
AU2002338270A1 (en) * 2001-04-02 2002-10-15 Akamai Technologies, Inc. Scalable, high performance and highly available distributed storage system for internet content
MXPA03010791A (es) * 2001-05-25 2004-03-02 Boehringer Ingelheim Pharma Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias.
EP2403219B1 (en) * 2001-09-28 2014-10-22 Level 3 CDN International, Inc. Method for name to address resolution
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7305429B2 (en) * 2002-06-10 2007-12-04 Utstarcom, Inc. Method and apparatus for global server load balancing
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
CN100549010C (zh) * 2003-11-03 2009-10-14 贝林格尔.英格海姆国际有限公司 制备噻托铵盐类的方法,噻托铵盐类及含有该盐类的医药制剂
PE20050485A1 (es) * 2003-11-03 2005-10-05 Boehringer Ingelheim Int Nuevas sales de tiotropio, procedimiento para su preparacion, asi como formulaciones medicamentosas que las contienen
DE102004041253A1 (de) * 2004-08-26 2006-03-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen
EP1896026B1 (en) * 2005-06-15 2013-10-09 Boehringer Ingelheim International GmbH Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
PL1910354T3 (pl) 2017-04-28
ECSP088138A (es) 2008-02-20
TW201418253A (zh) 2014-05-16
CN104356129A (zh) 2015-02-18
US20150225395A1 (en) 2015-08-13
WO2007012626A3 (de) 2010-05-06
US20100210844A1 (en) 2010-08-19
NZ566039A (en) 2011-07-29
CA2616222C (en) 2014-09-23
NO20076681L (no) 2008-02-13
TWI486346B (zh) 2015-06-01
US20130116435A1 (en) 2013-05-09
TW200738704A (en) 2007-10-16
NO20170613A1 (no) 2008-02-13
MX2008001093A (es) 2008-03-11
DK1910354T3 (en) 2017-02-13
ES2613952T3 (es) 2017-05-29
CA2616222A1 (en) 2007-02-01
EP1910354A2 (de) 2008-04-16
JP2009507769A (ja) 2009-02-26
ZA200711113B (en) 2010-08-25
BRPI0614062B1 (pt) 2020-11-17
EP3153512A1 (de) 2017-04-12
EA014271B1 (ru) 2010-10-29
TWI486345B (zh) 2015-06-01
IL188989A0 (en) 2008-08-07
TW201418252A (zh) 2014-05-16
JP5210861B2 (ja) 2013-06-12
TWI443097B (zh) 2014-07-01
KR20080032634A (ko) 2008-04-15
EP1910354B1 (de) 2016-11-09
WO2007012626A2 (de) 2007-02-01
NO340877B1 (no) 2017-07-03
CN101309920A (zh) 2008-11-19
IL188989A (en) 2012-10-31
BRPI0614062B8 (pt) 2021-05-25
DE102005035112A1 (de) 2007-02-15
EA200800324A1 (ru) 2008-08-29
AU2006274012A1 (en) 2007-02-01
BRPI0614062A2 (pt) 2011-03-09
KR101299929B1 (ko) 2013-08-27
AU2006274012B2 (en) 2011-11-03
AR057690A1 (es) 2007-12-12
US20140323732A1 (en) 2014-10-30
US20070027320A1 (en) 2007-02-01
HUE032259T2 (en) 2017-09-28

Similar Documents

Publication Publication Date Title
UA94914C2 (ru) Способ получения солей тиотропия
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
SG10201406658VA (en) Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
HK1116185A1 (en) Method for producing dihydroquinazolines
TW200617006A (en) New process for the manufacture of tiotropium salts
EP1917220A4 (en) SYNTHETIZED HYBRID FASCINAL COMPOSITION, METHOD AND ARTICLE MADE WITH THE PROCESS
MX2007000224A (es) Uso de 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas en el tratamiento de nauseas y vomitos.
MX2010006143A (es) Azolilmetiloxiranos, su uso y agentes que lo contienen.
GEP20084361B (en) Piperidinylcarbonyl-pyrro-lidines and their use as melanocortin agonists
WO2008090193A3 (de) Verfahren zur herstellung von betamimetika
MY148182A (en) Method of relating different products by a common feature
MXPA05011962A (es) Oxiarenos substituidos.
RS20060297A (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
TW200730521A (en) Triazine compounds having amino-and carboxyl-containing substituents
DE602005008380D1 (de) Sicherheitstinte
UA91733C2 (ru) Способ получения кристаллической формы орлистата
MXPA06002882A (es) Dispersiones de adhesivo acuosas.
UA96149C2 (en) Method for producing 4-oxoquinoline compound
WO2007009887A3 (de) Bariumsulfat enthaltende zubereitung
EP1939184A4 (en) 1,3-DIIODOHYDANTOIN COMPOUND AND PROCESS FOR PRODUCING THE SAME
EP1930310A4 (en) PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONALDEHYDE
TW200706581A (en) Markierte anorganische additive
MX2010001962A (es) Procedimiento para preparar 4-aminobut-2-enolidos.
MX2007007045A (es) Estabilizador uv para pmma.
TW200724037A (en) Granular lecithins, granular lysolecithins, process for producing granular lecithins and granular lysolecithins and compositions containing granular lecithins and granular lysolecithins